Huma licenses the GDm-Health gestational diabetes app to Somerset trust
- Somerset NHS Foundation Trust
- South West
- Single tender action (below threshold)
- 20 May 2026 to 19 May 2027
Somerset NHS Foundation Trust buys licences and support for GDm-Health, an app for patients with gestational diabetes, from Huma Therapeutics Limited.
GDm-Health lets clinicians monitor patients' blood glucose remotely. It fits into maternity teams' clinical workflows, analysing readings as they come in and helping staff manage their patients.
The trust awarded the contract directly, without a competition, in April 2026. It is worth £10,620 and runs to May 2027.
Contract ends May 2027
- What
- Remote patient monitoring and virtual ward technology
- Supplier
- Huma Therapeutics Limited
- Value
- £10,620
- How it was bought
- Single tender action (below threshold)
- Dates and next
- May 2026 to May 2027